IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
0.735
-0.085 (-10.41%)
Nov 21, 2024, 2:14 PM EST - Market open
IO Biotech Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | - | -86.08 | -71.46 | -67.88 | -12.04 | -10.74 |
| Depreciation & Amortization | - | 0.76 | 0.54 | 0 | - | - |
| Stock-Based Compensation | - | 8.06 | 7.04 | 1.79 | 0.06 | 0.13 |
| Other Operating Activities | - | -0.33 | -0.04 | 26.22 | 1.87 | 0.83 |
| Change in Accounts Payable | - | -0.13 | 0.08 | 3.41 | -0.48 | 0.1 |
| Change in Other Net Operating Assets | - | 5.99 | 4.12 | -4.18 | 0.62 | 0.79 |
| Operating Cash Flow | - | -71.74 | -59.73 | -40.65 | -9.96 | -8.89 |
| Capital Expenditures | - | -0.32 | -0.69 | -0.15 | - | - |
| Investing Cash Flow | - | -0.32 | -0.69 | -0.15 | - | - |
| Short-Term Debt Issued | - | - | - | - | - | 9.01 |
| Total Debt Issued | - | - | - | - | - | 9.01 |
| Net Debt Issued (Repaid) | - | - | - | - | - | 9.01 |
| Issuance of Common Stock | - | 75.06 | - | 115.12 | - | - |
| Other Financing Activities | - | -3.2 | - | -12.11 | -0.01 | - |
| Financing Cash Flow | - | 71.86 | - | 252.95 | 5.1 | 9.01 |
| Foreign Exchange Rate Adjustments | - | 0.8 | -8.52 | -3.76 | 0.41 | -0.25 |
| Net Cash Flow | - | 0.6 | -68.94 | 208.39 | -4.44 | -0.13 |
| Free Cash Flow | - | -72.06 | -60.42 | -40.8 | -9.96 | -8.89 |
| Free Cash Flow Per Share | - | -1.66 | -2.10 | -9.41 | -56.19 | -50.17 |
| Levered Free Cash Flow | - | -42.19 | -33.5 | -25.08 | -6.09 | - |
| Unlevered Free Cash Flow | - | -42.19 | -33.32 | -24.85 | -6.08 | - |
| Change in Net Working Capital | 0.3 | -6.47 | -4.43 | 0.72 | -0.2 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.